Gene: Rab6b (RAB6B, member RAS oncogene family) Mus musculus
Analyze
Symbol:
Rab6b
Name:
RAB6B, member RAS oncogene family
Description:
Predicted to have GTPase activity and myosin V binding activity. Predicted to be involved in several processes, including Golgi vesicle transport; Rab protein signal transduction; and retrograde transport, endosome to Golgi. Predicted to localize to the Golgi apparatus and presynapse. Is expressed in several structures, including nasal cavity epithelium; nervous system; and neural retina. Orthologous to human RAB6B (RAB6B, member RAS oncogene family); INTERACTS WITH 1,1-dichloroethene; 2,3,7,8-tetrachlorodibenzodioxine; 3,4-methylenedioxymethamphetamine.
Type:
protein-coding
RefSeq Status:
PROVISIONAL
Also known as:
9630015C03; AI844641; C330006L04Rik; D9Bwg0185e; ras-related protein Rab-6B
Orthologs:
Species
Gene symbol and name
Data Source
Assertion derived from
less info ...
Orthologs 1
Homo sapiens (human):
RAB6B (RAB6B, member RAS oncogene family)
HGNC
Ensembl, HGNC, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, OrthoMCL, Panther, PhylomeDB, Treefam
Rattus norvegicus (Norway rat):
Rab6b (RAB6B, member RAS oncogene family)
HGNC
Treefam, OrthoMCL, NCBI, OMA, HomoloGene, Panther, OrthoDB, Ensembl
Chinchilla lanigera (long-tailed chinchilla):
Rab6b (RAB6B, member RAS oncogene family)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Pan paniscus (bonobo/pygmy chimpanzee):
RAB6B (RAB6B, member RAS oncogene family)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Canis lupus familiaris (dog):
RAB6B (RAB6B, member RAS oncogene family)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Ictidomys tridecemlineatus (thirteen-lined ground squirrel):
Rab6b (RAB6B, member RAS oncogene family)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Sus scrofa (pig):
RAB6B (RAB6B, member RAS oncogene family)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Other homologs 2
Homo sapiens (human):
RAB6A (RAB6A, member RAS oncogene family)
HGNC
EggNOG, OrthoDB
Homo sapiens (human):
RAB26 (RAB26, member RAS oncogene family)
HGNC
Panther
Homo sapiens (human):
RAB37 (RAB37, member RAS oncogene family)
HGNC
Panther
Homo sapiens (human):
RAB33B (RAB33B, member RAS oncogene family)
HGNC
Panther
Homo sapiens (human):
RAB33A (RAB33A, member RAS oncogene family)
HGNC
Panther
Homo sapiens (human):
RAB41 (RAB41, member RAS oncogene family)
HGNC
Treefam
Homo sapiens (human):
RAB6C (RAB6C, member RAS oncogene family)
HGNC
OrthoDB
Homo sapiens (human):
RAB6D (RAB6D, member RAS oncogene family)
HGNC
OrthoDB
Alliance orthologs 3
Rattus norvegicus (Norway rat):
Rab6b (RAB6B, member RAS oncogene family)
Alliance
DIOPT (Ensembl Compara, OMA, OrthoFinder, PANTHER, PhylomeDB, TreeFam)
Homo sapiens (human):
RAB6B (RAB6B, member RAS oncogene family)
Alliance
DIOPT (Ensembl Compara, HGNC, Hieranoid, InParanoid, OMA, OrthoFinder, OrthoInspector, PANTHER, PhylomeDB, Roundup, TreeFam)
Danio rerio (zebrafish):
rab6bb (RAB6B, member RAS oncogene family b)
Alliance
DIOPT (Ensembl Compara, OrthoFinder, PANTHER, TreeFam, ZFIN)
Danio rerio (zebrafish):
rab41 (RAB41, member RAS oncogene family)
Alliance
DIOPT (OrthoFinder, PANTHER, Roundup)
Danio rerio (zebrafish):
rab6ba (RAB6B, member RAS oncogene family a)
Alliance
DIOPT (Ensembl Compara, Hieranoid, OMA, OrthoFinder, PANTHER, PhylomeDB, TreeFam, ZFIN)
Caenorhabditis elegans (roundworm):
rab-6.1
Alliance
DIOPT (OrthoFinder, PANTHER, PhylomeDB)
Drosophila melanogaster (fruit fly):
Rab6
Alliance
DIOPT (Ensembl Compara, Hieranoid, InParanoid, OrthoFinder, OrthoInspector, PANTHER, PhylomeDB, TreeFam)
Saccharomyces cerevisiae (baker's yeast):
YPT6
Alliance
DIOPT (Ensembl Compara, Hieranoid, InParanoid, OMA, OrthoFinder, OrthoInspector, PANTHER, PhylomeDB, TreeFam)
Caenorhabditis elegans (roundworm):
rab-6.2
Alliance
DIOPT (Ensembl Compara, Hieranoid, InParanoid, OMA, OrthoFinder, OrthoInspector, PANTHER, PhylomeDB, TreeFam)
Latest Assembly:
GRCm38 - Mouse Genome Assembly GRCm38
Position:
Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm38 9 103,111,667 - 103,185,276 (+) NCBI GRCm38 GRCm38 mm10 GRCm38 MGSCv37 9 103,014,404 - 103,087,600 (+) NCBI GRCm37 mm9 NCBIm37 MGSCv36 9 102,970,224 - 103,043,420 (+) NCBI mm8 Celera 9 102,662,484 - 102,735,933 (+) NCBI Celera Cytogenetic Map 9 F1 NCBI cM Map 9 54.88 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Gene-Chemical Interaction Annotations
1,1-dichloroethene decreases expression EXP 6480464 vinylidene chloride results in decreased expression of RAB6B mRNA CTD PMID:26682919 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of RAB6B mRNA CTD PMID:21570461 3,4-methylenedioxymethamphetamine increases expression EXP 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of RAB6B mRNA CTD PMID:20188158 4-hydroxyphenyl retinamide increases expression EXP 6480464 Fenretinide results in increased expression of RAB6B mRNA CTD PMID:28973697 antirheumatic drug increases expression ISO RGD:1320580 6480464 Antirheumatic Agents results in increased expression of RAB6B mRNA CTD PMID:24449571 atrazine increases expression ISO RGD:1320580 6480464 Atrazine results in increased expression of RAB6B mRNA CTD PMID:22378314 benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of RAB6B mRNA CTD PMID:21569818 bis(2-ethylhexyl) phthalate multiple interactions ISO RGD:1309958 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of RAB6B mRNA CTD PMID:31199487 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of RAB6B promoter CTD PMID:27312807 bisphenol A decreases expression ISO RGD:1309958 6480464 bisphenol A results in decreased expression of RAB6B mRNA CTD PMID:25181051 Butylbenzyl phthalate multiple interactions ISO RGD:1309958 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of RAB6B mRNA CTD PMID:31199487 cadmium dichloride increases expression ISO RGD:1320580 6480464 Cadmium Chloride results in increased expression of RAB6B mRNA CTD PMID:21457566 cadmium dichloride decreases expression ISO RGD:1320580 6480464 Cadmium Chloride results in decreased expression of RAB6B mRNA CTD PMID:26472689 carbamazepine affects expression ISO RGD:1320580 6480464 Carbamazepine affects the expression of RAB6B mRNA CTD PMID:25979313 carbon nanotube decreases expression EXP 6480464 Nanotubes, Carbon analog results in decreased expression of RAB6B mRNA, Nanotubes, Carbon results in decreased expression of RAB6B mRNA CTD PMID:25554681 ciguatoxin CTX1B affects expression EXP 6480464 Ciguatoxins affects the expression of RAB6B mRNA CTD PMID:18353800 cisplatin increases expression ISO RGD:1320580 6480464 Cisplatin results in increased expression of RAB6B mRNA CTD PMID:27392435 cisplatin multiple interactions ISO RGD:1320580 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of RAB6B mRNA CTD PMID:27392435 cyclosporin A decreases expression ISO RGD:1320580 6480464 Cyclosporine results in decreased expression of RAB6B mRNA CTD PMID:27989131 dibutyl phthalate multiple interactions ISO RGD:1309958 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of RAB6B mRNA CTD PMID:31199487 diethyl phthalate multiple interactions ISO RGD:1309958 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of RAB6B mRNA CTD PMID:31199487 diisobutyl phthalate multiple interactions ISO RGD:1309958 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of RAB6B mRNA CTD PMID:31199487 diisononyl phthalate multiple interactions ISO RGD:1309958 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of RAB6B mRNA CTD PMID:31199487 dorsomorphin multiple interactions ISO RGD:1320580 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RAB6B mRNA CTD PMID:27188386 doxorubicin decreases expression ISO RGD:1320580 6480464 Doxorubicin results in decreased expression of RAB6B mRNA CTD PMID:29803840 ethanol multiple interactions EXP 6480464 Ethanol affects the expression of and affects the splicing of RAB6B mRNA CTD PMID:30319688 furan increases expression ISO RGD:1309958 6480464 furan results in increased expression of RAB6B mRNA CTD PMID:27387713 gamma-tocopherol increases expression EXP 6480464 Tocopherols results in increased expression of RAB6B mRNA CTD PMID:17654050 hydrogen peroxide affects expression ISO RGD:1320580 6480464 Hydrogen Peroxide affects the expression of RAB6B mRNA CTD PMID:20044591 hydroquinone O-beta-D-glucopyranoside decreases expression ISO RGD:1320580 6480464 Arbutin results in decreased expression of RAB6B mRNA CTD PMID:17103032 kojic acid decreases expression ISO RGD:1320580 6480464 kojic acid results in decreased expression of RAB6B mRNA CTD PMID:16595896 lead(0) affects expression ISO RGD:1320580 6480464 Lead affects the expression of RAB6B mRNA CTD PMID:28903495 lead(2+) affects expression ISO RGD:1320580 6480464 Lead affects the expression of RAB6B mRNA CTD PMID:28903495 N-nitrosodiethylamine increases expression EXP 6480464 Diethylnitrosamine results in increased expression of RAB6B mRNA CTD PMID:17942915 N-nitrosodiethylamine multiple interactions EXP 6480464 MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of RAB6B mRNA] CTD PMID:17942915 nickel atom decreases expression ISO RGD:1320580 6480464 Nickel results in decreased expression of RAB6B mRNA CTD PMID:24768652 , PMID:25583101 paracetamol increases expression ISO RGD:1320580 6480464 Acetaminophen results in increased expression of RAB6B mRNA CTD PMID:26690555 phenylmercury acetate decreases expression ISO RGD:1320580 6480464 Phenylmercuric Acetate results in decreased expression of RAB6B mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1320580 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RAB6B mRNA CTD PMID:27188386 potassium dichromate increases expression ISO RGD:1320580 6480464 Potassium Dichromate results in increased expression of RAB6B protein CTD PMID:23718831 SB 431542 multiple interactions ISO RGD:1320580 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RAB6B mRNA CTD PMID:27188386 silicon dioxide decreases expression ISO RGD:1320580 6480464 Silicon Dioxide analog results in decreased expression of RAB6B mRNA CTD PMID:25895662 sodium dichromate increases expression ISO RGD:1309958 6480464 sodium bichromate results in increased expression of RAB6B mRNA CTD PMID:22561333 titanium dioxide decreases expression EXP 6480464 titanium dioxide results in decreased expression of RAB6B mRNA CTD PMID:23557971 , PMID:27760801 titanium dioxide decreases expression ISO RGD:1309958 6480464 titanium dioxide results in decreased expression of RAB6B mRNA CTD PMID:30012374 tocopherol increases expression EXP 6480464 Tocopherols results in increased expression of RAB6B mRNA CTD PMID:17654050 trichostatin A increases expression ISO RGD:1320580 6480464 trichostatin A results in increased expression of RAB6B mRNA CTD PMID:24935251 trichostatin A decreases expression ISO RGD:1320580 6480464 trichostatin A results in decreased expression of RAB6B mRNA CTD PMID:24935251 trimellitic anhydride decreases expression EXP 6480464 trimellitic anhydride results in decreased expression of RAB6B mRNA CTD PMID:19042947 troglitazone decreases expression EXP 6480464 troglitazone results in decreased expression of RAB6B mRNA CTD PMID:28973697 valproic acid affects expression ISO RGD:1320580 6480464 Valproic Acid affects the expression of RAB6B mRNA CTD PMID:25979313 valproic acid increases expression ISO RGD:1320580 6480464 Valproic Acid results in increased expression of RAB6B mRNA CTD PMID:19101580 more ...
Gene Ontology Annotations